The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer.
 
Xinghao Ai
No Relationships to Disclose
 
Yun Yan Zhang
No Relationships to Disclose
 
Tongmei Zhang
No Relationships to Disclose
 
Tienan Yi
No Relationships to Disclose
 
Mingjun Li
No Relationships to Disclose
 
Wenxiu Yao
No Relationships to Disclose
 
Liang Han
No Relationships to Disclose
 
Longhua Sun
No Relationships to Disclose
 
Anwen Liu
No Relationships to Disclose
 
Qi Mei
No Relationships to Disclose
 
Guang Han
No Relationships to Disclose
 
Zhen Zhang
No Relationships to Disclose
 
Yinyin Li
No Relationships to Disclose
 
Lu Li
No Relationships to Disclose
 
Li Zheng
No Relationships to Disclose
 
Yong Fang
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Jason Wu
Employment - Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Leadership - Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Stock and Other Ownership Interests - Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Honoraria - Suzhou Zelgen Biopharmaceuticals Co., Ltd.
 
Shun Lu
Leadership - Innovent BIOLOGICS, INC; Shanghai Fosun; Simcere Zaiming
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; InventisBio Co. Ltd; Menarini; Pfizer; Roche; Simcere; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh Pharma; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Hansoh (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); Lilly Suzhou Pharmaceutical Co. (Inst); Roche (Inst)